NCI
Get informed when a big investor buys or sells
+ FollowOvervalued by 168.9% based on the discounted cash flow analysis.
| Market cap | $6.59 Million |
|---|---|
| Enterprise Value | $54.61 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.65 |
| Beta | -2.87 |
| Outstanding Shares | 508,000 |
| P/E Ratio | -101.71 |
|---|---|
| PEG | 34 |
| Price to Sales | 0.06 |
| Price to Book Ratio | 0.12 |
| Enterprise Value to Revenue | 0.48 |
| Enterprise Value to EBIT | 32.9 |
| Enterprise Value to Net Income | -135 |
| Total Debt to Enterprise | 0.92 |
| Debt to Equity | 0.89 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data